Actively Recruiting

Phase Not Applicable
Age: 40Years - 90Years
All Genders
ID06471127

Genetic and MRI Biomarkers of Neuroplasticity Predict Aphasia Recovery and Phenotypes

Led by University of Wisconsin, Madison · Updated on 2025-10-23

90

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

U

University of Wisconsin, Madison

Lead Sponsor

N

National Institutes of Health (NIH)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Aphasia, a language disorder often resulting from stroke, can cause serious challenges including social isolation and reduced quality of life. Recovery from aphasia varies widely among individuals and depends on the brain's ability to reorganize and repair itself through neuroplasticity at both network and molecular levels. This research aims to study genetic and brain network markers linked to neuroplasticity to better understand variations in aphasia recovery and to support future development of personalized treatments. Participants will engage in a behavioral pseudoword learning task where they view pairs of novel objects and hear names of one object, responding by identifying the correct item. This task includes multiple learning blocks with feedback and test blocks assessing immediate and retained learning. The study will measure genetic markers and brain connectivity through MRI to explore their connections with language recovery over time. During the study, participants will be assessed at several time points up to at least one year post-stroke. Evaluations include aphasia severity, semantic, phonological, noun and verb processing, pseudoword learning, and verbal learning. Researchers will use these measures alongside genetic and MRI data to understand recovery patterns. The study spans multiple months involving follow-up assessments to monitor progress and outcomes, with the goal of improving aphasia prognosis and treatment strategies.

CONDITIONS

Brief Title

Neuroplasticity Biomarkers in Aphasia

Who Can Participate

Age: 40Years - 90Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Ages 40 to 90 years
  • Right-handed before stroke
  • Proficient in English
  • History of a single ischemic stroke in the middle cerebral artery territory lateralized to the left or right cerebral hemisphere
  • Presence of aphasia (language impairment)
  • Ability to understand the study and provide informed consent
  • For Aim 1: acute or subacute stroke at enrollment
  • For Aims 2-3: stroke at least 12 months old (chronic)
  • Medically stable
Not Eligible

You will not qualify if you...

  • History of significant medical or neurological disorders other than stroke
  • History of significant or poorly controlled psychiatric disorders
  • Current abuse of alcohol or drugs
  • Clinically significant and uncorrected vision or hearing loss
  • Receipt of treatments beyond standard stroke care such as Plavix, aspirin (81-300 mg daily), beta-blockers, diabetes or cholesterol medications, thrombolytics (e.g., tPA), or anticoagulants like Heparin, Warfarin/Coumadin

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Outpatient Treatment

Duration - Approximately 1 week

Participants complete a behavioral pseudoword learning task involving multiple trials and learning blocks designed to assess language processing and verbal learning.

1 baseline visit and 1 follow-up visit

Long-term Monitoring

Duration - Up to 1 year post-stroke

Participants are observed over time to assess aphasia recovery and language function through follow-up assessments at multiple timepoints post-stroke.

Visits at 3 months, 6 months, and 1 year post-stroke

Trial Site Locations

Total: 1 location

1

UW School of Medicine and Public Health

Madison, Wisconsin, United States, 53792

Actively Recruiting

Loading map...

Research Team

H

Haley Dresang, PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

OTHER

Number of Arms

1

Similar Trials

Efficacy and Target Engagement of a Digital Intervention to ...

Executive Dysfunction

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here